ClinicalTrials.govpublic full text
A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants
biological availability, healthy participants, coronavirus disease 2019 (covid-19), severe acute respiratory syndrome coronavirus 2 (sars-cov-2), nirmatrelvir, paxlovid, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 969305
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.